Arteris, Inc. (NASDAQ:AIP - Get Free Report ) VP Paul L. Alpern sold 11,250 shares of the firm's stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $6.39, for a total transaction of $71,887.50. Following the transaction, the vice president now directly owns 81,042 shares of the company's stock, valued at $517,858.38. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink .
Get Arteris alerts:
Sign Up
Arteris Stock Performance Shares of AIP traded up $2.28 during trading hours on Friday, hitting $8.21. The stock had a trading volume of 1,103,765 shares, compared to its average volume of 151,353. The firm has a 50-day moving average price of $6.91 and a 200 day moving average price of $6.17. Arteris, Inc. has a fifty-two week low of $3.82 and a fifty-two week high of $8.24. The firm has a market capitalization of $315.02 million, a price-to-earnings ratio of -7.61 and a beta of 1.04. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.26 and a current ratio of 1.26.
Arteris (NASDAQ:AIP - Get Free Report ) last released its quarterly earnings data on Tuesday, February 20th. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.01). Arteris had a negative net margin of 68.70% and a negative return on equity of 150.71%. The firm had revenue of $12.50 million during the quarter, compared to analysts' expectations of $11.90 million. As a group, research analysts anticipate that Arteris, Inc. will post -0.9 EPS for the current year.
Hedge Funds Weigh In On Arteris A number of hedge funds have recently bought and sold shares of the business. Roubaix Capital LLC raised its position in Arteris by 77.1% during the third quarter. Roubaix Capital LLC now owns 254,744 shares of the company's stock worth $1,658,000 after acquiring an additional 110,916 shares during the period. Acuitas Investments LLC lifted its stake in Arteris by 34.1% in the 3rd quarter. Acuitas Investments LLC now owns 86,299 shares of the company's stock valued at $562,000 after buying an additional 21,946 shares in the last quarter. Barclays PLC acquired a new stake in Arteris in the 3rd quarter worth about $120,000. Ibex Investors LLC purchased a new stake in Arteris during the 3rd quarter worth approximately $99,000. Finally, Acadian Asset Management LLC raised its holdings in shares of Arteris by 120.1% during the third quarter. Acadian Asset Management LLC now owns 368,220 shares of the company's stock valued at $2,396,000 after acquiring an additional 200,950 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company's stock.
Wall Street Analyst Weigh In A number of research firms have recently weighed in on AIP. Wedbush reiterated an "outperform" rating and issued a $17.00 price objective on shares of Arteris in a research note on Tuesday, February 20th. Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 price target on shares of Arteris in a research report on Friday.
Check Out Our Latest Analysis on AIP
About Arteris (
Get Free Report )
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report